Pesticides & Agrochemicals · Founded 1987 · www.aimcopesticides.com · BSE 524288 · NSE AIMCO PESTI. · ISIN INE008B01013
No Notes Added Yet
Business
Aimco Pesticides Ltd. is an Indian company primarily engaged in the manufacturing and formulation of pesticides and agrochemical products. Its core business model involves developing, producing, and marketing various crop protection chemicals such as insecticides, fungicides, herbicides, and plant growth regulators. The company makes money by selling these products to distributors, directly to farmers, and potentially to other agrochemical companies (B2B). It aims to provide solutions that enhance agricultural productivity and protect crops from pests and diseases.
Revenue Mix
Specific revenue mix data is not available. However, typical segments for a company in this industry might include:
Technical Grade Products: Manufacturing active ingredients.
Formulations: Converting active ingredients into usable products for end-users.
Domestic Sales: Catering to the Indian agricultural market.
Exports: Supplying products to international markets.
Given its nature, the company likely derives revenue primarily from the sale of a diversified portfolio of formulated agrochemicals.
Industry
The Indian Pesticides & Agrochemicals industry is characterized by a mix of large multinational corporations and numerous domestic players. It is influenced by monsoons, agricultural policies, and global commodity prices. The industry is competitive, with players often vying for market share through product differentiation, pricing, and distribution reach. Aimco Pesticides Ltd. likely positions itself as a regional or national player, potentially focusing on specific product categories, generic off-patent molecules, or particular agricultural belts where it has a strong distribution network.
MOAT
Aimco Pesticides Ltd. may possess some competitive advantages, though likely not strong, wide moats:
Regulatory Expertise & Product Registrations: Ability to navigate the complex regulatory environment and secure necessary registrations for its products, creating a barrier to entry for new players.
Distribution Network: An established sales and distribution network, particularly in rural India, can be a significant asset for reaching farmers.
Manufacturing Efficiency/Cost Advantage: Expertise in low-cost manufacturing or formulation processes for specific products.
Product Portfolio: A diverse range of registered products can cater to various crop and pest issues, providing a comprehensive offering.
Growth Drivers
Agricultural Growth in India: Sustained growth in agricultural output and increasing awareness among farmers about crop protection.
Increasing Pest & Disease Incidence: Climate change and evolving pest resistance can drive demand for new and existing agrochemicals.
Government Initiatives: Support for agriculture, including subsidies and schemes that encourage modern farming practices.
Expansion into New Geographies/Crops: Venturing into new domestic markets or export destinations, and developing products for new crops.
Focus on Specialty Products: Developing and marketing niche or high-margin specialty chemicals.
Risks
Monsoon Dependency: Poor or erratic monsoons can significantly impact agricultural output and demand for agrochemicals.
Raw Material Price Volatility: Fluctuations in crude oil prices and other chemical intermediates can affect production costs and margins.
Intense Competition & Pricing Pressure: A fragmented industry can lead to price wars, eroding profitability.
Regulatory Changes: Stricter environmental regulations, product bans, or changes in registration processes can impact operations and product portfolios.
Product Obsolescence & R&D Risks: The need for continuous innovation to counter pest resistance and develop new, effective chemicals.
Counterfeit Products: The presence of counterfeit products in the market can undermine legitimate sales and brand reputation.
Management & Ownership
As is common with many Indian companies, Aimco Pesticides Ltd. is likely promoter-led, with the founding family or group holding a significant ownership stake. The quality of management would depend on their experience in the agrochemical sector, strategic vision, operational efficiency, and commitment to governance. Ownership structure typically involves a substantial portion held by the promoter group, with the remainder held by institutional and public shareholders.
Outlook
Aimco Pesticides Ltd. operates in a sector with fundamental demand drivers linked to global food security and agricultural productivity. The bull case rests on favorable monsoons, increasing farmer awareness, government support for agriculture, and the company's ability to innovate and expand its distribution network, potentially leveraging its expertise in generic formulations. The bear case highlights risks from adverse weather conditions, intense competition, volatile raw material prices, and stringent regulatory changes that could impact its product portfolio or cost structure. Overall, the company's future performance will depend on its operational efficiency, strategic product development, and ability to navigate the inherent cyclicality and regulatory landscape of the agrochemical industry in India.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 37 | 40 | 55 | 51 | 53 | 48 | 46 | 30 | 31 | 22 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 37 | 40 | 55 | 51 | 53 | 48 | 46 | 31 | 31 | 22 |
| Total Expenditure | 41 | 40 | 55 | 49 | 57 | 49 | 49 | 33 | 35 | 20 |
| Operating Profit | -3 | -0 | 0 | 2 | -5 | -1 | -3 | -2 | -4 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -5 | -2 | -1 | 1 | -7 | -2 | -5 | -3 | -5 | 1 |
| Provision for Tax | -1 | -0 | -0 | 0 | -2 | -1 | -1 | -1 | -1 | 0 |
| Profit After Tax | -4 | -2 | -1 | 1 | -5 | -1 | -4 | -3 | -4 | 1 |
| Adjustments | -0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | -4 | -2 | -1 | 1 | -5 | -1 | -4 | -3 | -4 | 1 |
| Adjusted Earnings Per Share | -4 | -1.6 | -1.1 | 0.5 | -5.3 | -1.5 | -4.1 | -2.6 | -4.2 | 0.6 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 97 | 99 | 109 | 197 | 185 | 176 | 312 | 206 | 207 | 198 | 154 | 129 |
| Other Income | 1 | 2 | 5 | 7 | 4 | 3 | 1 | 1 | 1 | 1 | 2 | 0 |
| Total Income | 98 | 102 | 114 | 204 | 189 | 179 | 313 | 207 | 208 | 199 | 156 | 130 |
| Total Expenditure | 93 | 89 | 105 | 191 | 175 | 169 | 294 | 204 | 215 | 201 | 166 | 137 |
| Operating Profit | 5 | 13 | 9 | 13 | 14 | 10 | 19 | 3 | -6 | -2 | -11 | -7 |
| Interest | 0 | 0 | 0 | 1 | 2 | 4 | 1 | 2 | 3 | 3 | 2 | 0 |
| Depreciation | 1 | 1 | 1 | 2 | 3 | 2 | 3 | 4 | 4 | 4 | 3 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 4 | 12 | 8 | 11 | 9 | 3 | 15 | -3 | -13 | -10 | -16 | -12 |
| Provision for Tax | -0 | 0 | 3 | 3 | 3 | 1 | 4 | -1 | -3 | -2 | -4 | -3 |
| Profit After Tax | 5 | 11 | 5 | 8 | 7 | 2 | 11 | -2 | -10 | -7 | -12 | -10 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 5 | 11 | 5 | 8 | 7 | 2 | 11 | -2 | -10 | -7 | -12 | -10 |
| Adjusted Earnings Per Share | 4.9 | 12.3 | 5.2 | 8.1 | 6.9 | 2.2 | 11.1 | -2.3 | -10.5 | -7.4 | -12.5 | -10.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -22% | -9% | -3% | 5% |
| Operating Profit CAGR | 0% | NAN% | NAN% | NAN% |
| PAT CAGR | 0% | 0% | NAN% | NAN% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -37% | -29% | -16% | -4% |
| ROE Average | -51% | -33% | -16% | 14% |
| ROCE Average | -34% | -22% | -7% | 22% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 8 | 18 | 29 | 35 | 39 | 41 | 50 | 46 | 35 | 30 | 18 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 2 | 0 | 0 |
| Other Non-Current Liabilities | 1 | -1 | -0 | 11 | 3 | 13 | 8 | 12 | 8 | 6 | 2 |
| Total Current Liabilities | 47 | 43 | 45 | 63 | 87 | 87 | 117 | 96 | 109 | 143 | 109 |
| Total Liabilities | 56 | 60 | 73 | 109 | 130 | 143 | 176 | 155 | 155 | 179 | 129 |
| Fixed Assets | 4 | 7 | 14 | 17 | 19 | 19 | 25 | 28 | 27 | 26 | 24 |
| Other Non-Current Assets | 3 | 9 | 2 | 13 | 6 | 20 | 11 | 15 | 19 | 16 | 15 |
| Total Current Assets | 49 | 43 | 57 | 79 | 105 | 104 | 140 | 111 | 109 | 137 | 89 |
| Total Assets | 56 | 60 | 73 | 109 | 130 | 143 | 176 | 155 | 155 | 179 | 129 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 2 | 2 | 0 | 2 | 4 | 6 | 4 | 4 | 1 | 3 | 4 |
| Cash Flow from Operating Activities | -0 | 7 | -1 | 10 | 3 | 8 | 23 | -10 | 7 | 3 | 6 |
| Cash Flow from Investing Activities | 1 | -9 | -3 | -6 | -5 | -6 | -9 | -2 | -7 | -2 | -1 |
| Cash Flow from Financing Activities | -0 | 0 | 6 | -2 | 4 | -4 | -13 | 9 | 1 | -0 | -7 |
| Net Cash Inflow / Outflow | 1 | -2 | 1 | 2 | 2 | -2 | 0 | -3 | 2 | 1 | -3 |
| Closing Cash & Cash Equivalent | 2 | 0 | 2 | 4 | 6 | 4 | 4 | 1 | 3 | 4 | 1 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 4.93 | 12.27 | 5.2 | 8.05 | 6.94 | 2.19 | 11.12 | -2.28 | -10.48 | -7.4 | -12.47 |
| CEPS(Rs) | 5.49 | 12.92 | 6.22 | 9.85 | 9.71 | 4.48 | 13.98 | 1.49 | -6.03 | -3.22 | -8.98 |
| DPS(Rs) | 0 | 0 | 1 | 1.5 | 1.5 | 1 | 2 | 1 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 8.82 | 19.65 | 29.93 | 36.62 | 40.35 | 42.58 | 52.69 | 48.3 | 36.55 | 30.55 | 18.06 |
| Core EBITDA Margin(%) | 4.24 | 10.26 | 3.61 | 3.38 | 5.48 | 3.83 | 5.74 | 1.02 | -3.71 | -1.82 | -7.91 |
| EBIT Margin(%) | 4.51 | 11.65 | 7.46 | 5.92 | 6.06 | 4.32 | 5.13 | -0.19 | -5.15 | -3.29 | -9.07 |
| Pre Tax Margin(%) | 4.25 | 11.4 | 7.18 | 5.6 | 4.99 | 1.82 | 4.65 | -1.36 | -6.43 | -4.85 | -10.25 |
| PAT Margin (%) | 4.64 | 11.09 | 4.52 | 3.91 | 3.59 | 1.19 | 3.42 | -1.06 | -4.85 | -3.66 | -7.93 |
| Cash Profit Margin (%) | 5.17 | 11.68 | 5.41 | 4.79 | 5.03 | 2.45 | 4.3 | 0.69 | -2.79 | -1.59 | -5.71 |
| ROA(%) | 8.33 | 19.56 | 7.51 | 8.49 | 5.57 | 1.54 | 6.69 | -1.32 | -6.5 | -4.35 | -7.93 |
| ROE(%) | 77.56 | 86.23 | 21.27 | 24.2 | 18.02 | 5.28 | 23.35 | -4.52 | -24.71 | -22.32 | -51.3 |
| ROCE(%) | 74.83 | 90.42 | 35.09 | 36.58 | 27.01 | 15.28 | 31.46 | -0.72 | -19.02 | -12.61 | -34.11 |
| Receivable days | 105.15 | 73.67 | 53.98 | 29.46 | 44.4 | 56.97 | 38.9 | 58 | 62.65 | 89.5 | 91.71 |
| Inventory Days | 53.69 | 69.12 | 77.31 | 68.42 | 103.48 | 124.05 | 81.34 | 137.6 | 114.45 | 115.56 | 150.54 |
| Payable days | 198.56 | 183.94 | 142.25 | 94.8 | 150.32 | 181.09 | 133.78 | 211.2 | 168.54 | 236.58 | 300.27 |
| PER(x) | 7.32 | 7.66 | 30.37 | 15.91 | 7.14 | 40.6 | 12.47 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 4.09 | 4.79 | 5.28 | 3.5 | 1.23 | 2.09 | 2.63 | 2.27 | 2.48 | 2.5 | 1.99 |
| Dividend Yield(%) | 0 | 0 | 0.63 | 1.17 | 3.03 | 1.12 | 1.44 | 0.91 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.32 | 0.87 | 1.37 | 0.6 | 0.27 | 0.52 | 0.41 | 0.56 | 0.49 | 0.45 | 0.31 |
| EV/Core EBITDA(x) | 6.23 | 6.91 | 16.24 | 8.89 | 3.63 | 9.35 | 6.85 | 35.98 | -15.8 | -37.27 | -4.54 |
| Net Sales Growth(%) | -41.31 | 2.57 | 9.79 | 80.58 | -6.09 | -5.15 | 77.58 | -33.91 | 0.5 | -4.61 | -22.15 |
| EBIT Growth(%) | 23.99 | 169.15 | -30.97 | 41.93 | -3.74 | -32.48 | 110.89 | -102.45 | -2622.53 | 39.18 | -114.86 |
| PAT Growth(%) | 56.7 | 149.15 | -56.07 | 54.9 | -13.88 | -68.41 | 407.72 | -120.5 | -359.71 | 27.9 | -68.39 |
| EPS Growth(%) | 56.7 | 149.05 | -57.64 | 54.9 | -13.88 | -68.41 | 407.71 | -120.5 | -359.71 | 29.37 | -68.39 |
| Debt/Equity(x) | 0 | 0 | 0 | 0 | 0.24 | 0.25 | 0 | 0.27 | 0.53 | 0.66 | 0.83 |
| Current Ratio(x) | 1.04 | 1.01 | 1.28 | 1.26 | 1.21 | 1.19 | 1.19 | 1.15 | 1 | 0.96 | 0.82 |
| Quick Ratio(x) | 0.64 | 0.56 | 0.69 | 0.52 | 0.54 | 0.49 | 0.53 | 0.35 | 0.52 | 0.45 | 0.32 |
| Interest Cover(x) | 17.68 | 47.64 | 26.48 | 18.55 | 5.63 | 1.73 | 10.85 | -0.16 | -4.04 | -2.1 | -7.68 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0.2 | 0.12 | 0 | 0.12 | 0.21 | 0.26 | 0.41 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.5 | 53.5 | 53.5 | 53.5 | 54.45 | 54.45 | 54.45 | 54.45 | 54.45 | 54.45 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0 | 0 | 0 |
| Public | 46.43 | 46.43 | 46.43 | 46.43 | 45.48 | 45.48 | 45.48 | 45.55 | 45.55 | 45.55 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.51 | 0.51 | 0.51 | 0.51 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.45 | 0.45 | 0.45 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.96 | 0.96 | 0.96 | 0.96 | 0.98 | 0.98 | 0.98 | 0.98 | 0.98 | 0.98 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -22% | -9% | -3% | +5% |
| Operating Profit CAGR | — | 0% | 0% | 0% |
| PAT CAGR | — | — | 0% | 0% |
| Share Price CAGR | -37% | -29% | -16% | -4% |
| ROE Average | -51% | -33% | -16% | +14% |
| ROCE Average | -34% | -22% | -7% | +22% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.5 | 53.5 | 53.5 | 53.5 | 54.45 | 54.45 | 54.45 | 54.45 | 54.45 | 54.45 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0 | 0 | 0 |
| Public | 46.43 | 46.43 | 46.43 | 46.43 | 45.48 | 45.48 | 45.48 | 45.55 | 45.55 | 45.55 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.51 | 0.51 | 0.51 | 0.51 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 | 0.53 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | 0.45 | 0.45 | 0.45 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.96 | 0.96 | 0.96 | 0.96 | 0.98 | 0.98 | 0.98 | 0.98 | 0.98 | 0.98 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.